COHR

Business Context and Reporting Period

Company: II-VI Incorporated (filing as COHERENT CORP. in metadata, but text confirms II-VI)

Filing Type: Form 10-K (Annual Report)

Period Ended: June 30, 2005

II-VI Incorporated develops, manufactures, and markets high-technology materials and precision components for industrial, medical, military, security, and aerospace applications. Key product lines include infrared and near-infrared optical components, military infrared products, x-ray/gamma-ray sensors, silicon carbide substrates, and thermoelectric cooling solutions. A significant strategic event during the period was the acquisition of Marlow Industries, Inc. in December 2004, a global leader in thermoelectric products, which is now an operating unit within the Compound Semiconductor Group segment.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 29% to $194.0 million, driven by a 16% increase in the Infrared Optics segment, a 31% increase in Near-Infrared Optics (led by UV Filter product line ramp-up), and an 8% increase in Military Optics. The Compound Semiconductor Group revenues surged 160% primarily due to the inclusion of Marlow Industries.
• Earnings Expansion: Net earnings rose 43% to $24.8 million. This was fueled by revenue growth, production efficiencies from Asian facilities (Singapore and China), and a lower effective tax rate of 27% compared to 29% in the prior year.
• Debt Increase: Total debt increased significantly from $15.5 million to $45.0 million, primarily to finance the acquisition of Marlow Industries. The company replaced its credit facility with a $60.0 million secured agreement.
• Segment Performance: While Infrared and Near-Infrared segments showed strong growth, Military Optics bookings decreased 14% due to defense procurement delays. The Compound Semiconductor Group (excluding Marlow) saw a 23% decrease in bookings due to order cancellations from two OEM customers.

Guidance, Outlook, and Risks

Outlook for Fiscal 2006: Management projects revenues to range between $216 million and $222 million. Diluted earnings per share are expected to range from $0.84 to $0.88. This guidance reflects the anticipated implementation of SFAS 123(R), which requires expensing the fair value of stock options, expected to reduce EPS by approximately $0.06 to $0.88.

Key Risks and Contingencies:

• Supply Chain: The company relies on limited sources for critical raw materials like Zinc Selenide (ZnSe) and Hydrogen Selenide. A single outside source exists for ZnSe, and internal production of Hydrogen Selenide is critical to cost control.
• Raw Material Costs: Significant price increases in selenium (from ~$4/lb to ~$50/lb) have impacted the Infrared Optics segment.
• Government Dependence: A portion of revenue is derived from U.S. government contracts, which are subject to funding approvals and potential termination without warning.
• Accounting Changes: Adoption of SFAS 123(R) will result in non-cash charges affecting reported earnings.
• Legal: An ongoing appeal regarding a trade secret lawsuit where a jury verdict of $0.8 million was awarded, though punitive damages were denied.

Investor Verification Checklist

• Marlow Integration: Verify the realization of synergies and the full-year financial contribution of the Marlow Industries acquisition.
• Raw Material Pricing: Monitor the stability of selenium and other critical raw material costs and their impact on gross margins.
• Government Contract Stability: Assess the risk of funding cuts or delays in the defense sector, which impacted Military Optics bookings.
• Stock Option Expense: Confirm the actual impact of SFAS 123(R) adoption on fiscal 2006 earnings versus the projected $0.06-$0.08 reduction.
• Debt Covenants: Review compliance with the new $60.0 million credit facility covenants, including leverage and debt service coverage ratios.